The anti-inflammatory properties of humic substances: A mini review

Comprehensive mini-review of the anti-inflammatory properties of humic substances, covering peat preparations, potassium humate, and fulvic acid products. Uniquely valuable because it spans preclinical mechanisms through clinical trials.

Mechanisms (verified from full text)

• Cytokine inhibition: Potassium humate inhibits IL-1β, IL-6, IL-10, TNF-α production
• Complement inhibition: Inhibits both classical and alternative complement pathways
• NF-κB inhibition: Reduces NF-κB activation in LPS-stimulated endothelial cells
• Cell adhesion: Inhibits CR1/CR3 expression, preventing inflammatory cells from adhering to blood vessel walls near inflammation sites
• Phagocyte degranulation: Inhibits release of toxic substances from phagocytes

Clinical Evidence (verified from full text)

• Potassium humate reduced CRP levels in osteoarthritis patients (double-blind placebo-controlled trial)
• Oxifulvic acid topically reduced wheel-and-flare reaction in allergic patients, comparable to hydrocortisone
• Carbohydrate-derived fulvic acid reduced skin prick test response in atopic subjects
• Tolpa peat preparation showed cardioprotective and pro-angiogenic effects in rats

Safety (verified from full text)

• Potassium humate: safe up to 1g/kg daily in humans
• Fulvic acid: safe up to 1.8g per adult daily
• No significant adverse effects reported in reviewed trials

Table 1 — Summary of successful trials

Lists preclinical and clinical applications across: peat (topical/spa for dermatitis, psoriasis, RA, wounds), sapropel (wound healing in rats), Tolpa peat (cardioprotective in rats), oxifulvic acid (eczema, contact hypersensitivity), potassium humate (allergic rhinitis, osteoarthritis).